文献速递骨显像与常规 SPECT肿瘤 PET/CT

病态肥胖患者转移性骨病分期诊断的挑战:评估18F-氟化钠(NaF)PET-CT实用性的初步研究

Diagnostic Challenge of Staging Metastatic Bone Disease in the Morbidly Obese Patients: A Primary Study Evaluating the Usefulness of 18F-Sodium Fluoride (NaF) PET-CT.
PubMed 文献 · Clin Nucl Med · 2017-01-01

该回顾性研究纳入212例体重指数大于40 kg/m²的病态肥胖癌症患者,评估18F-氟化钠PET-CT对骨转移的诊断效能。结果显示灵敏度93.1%、特异度96.1%、阳性预测值90%、阴性预测值97.3%、准确率95.2%。作者认为18F-氟化钠PET-CT在病态肥胖患者中保持高诊断准确率,据此推断可作为首选功能显像方式。

要点

  • 病态肥胖患者中18F-氟化钠PET-CT诊断骨转移的灵敏度为93.1%、特异度为96.1%。
  • 该检查的阳性预测值90%、阴性预测值97.3%、准确率95.2%。
  • 作者认为18F-氟化钠PET-CT在病态肥胖患者中保持高诊断准确率。

核心结论

  • 作者认为18F-氟化钠PET-CT在病态肥胖患者中保持高诊断准确率,据此推断可作为这类患者的首选功能显像方式。

研究设计与样本

  • 回顾性分析212例体重指数大于40 kg/m²的病态肥胖癌症患者(体重指数45±5.1 kg/m²,平均年龄57岁,范围32-81岁),因恶性肿瘤骨分期转诊行18F-氟化钠PET-CT。
  • 所有患者按2.2 MBq/kg(0.06 mCi/kg)注射18F-氟化钠后行PET-CT扫描。

主要发现

  • 18F-氟化钠PET-CT结果:肯定良性145例、可能良性3例、不确定4例、可能恶性13例、肯定恶性47例。
  • 18F-氟化钠PET-CT的灵敏度93.1%、特异度96.1%、阳性预测值90%、阴性预测值97.3%、准确率95.2%(95%置信区间)。

关键数值与推荐

  • 18F-氟化钠PET-CT诊断骨转移的灵敏度93.1%、特异度96.1%、阳性预测值90%、阴性预测值97.3%、准确率95.2%(95%置信区间)。

临床怎么用

  • 作者认为18F-氟化钠PET-CT在病态肥胖患者中保持高诊断准确率,据此推断可作为这类患者的首选功能显像方式。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Optimizing diagnostic imaging may be challenging in obese patients. The quality of conventional bone scintigraphy can be poor in the morbidly obese due to a combination of factors including high background soft tissue activity. In comparison, sodium fluoride (F-NaF PET-CT) has a better target-to-background ratio attributed to rapid single-pass extraction and fast clearance from the soft tissues. The aim of the present study is to assess the diagnostic efficacy of F-NaF PET-CT in the evaluation of bone metastases in obese cancer patients. PATIENTS AND METHODS: Two hundred twelve morbidly obese patients (body mass index, 45 ± 5.1 kg/m; mean age, 57 years; range, 32-81 years) with body mass index greater than 40 kg/m referred for NaF PET-CT for osseous staging of malignancy were retrospectively analyzed. All patients underwent PET-CT scan by injecting 2.2 MBq/kg (0.06 mCi/kg) of F-NaF. RESULTS: F-NaF PET-CT was definitely benign in 145, possibly benign in 3, equivocal in 4, possibly malignant in 13, and definitely malignant in 47 patients. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of F-NaF PET-CT were 93.1%, 96.1%, 90%, 97.3%, and 95.2%, respectively (95% confidence interval). CONCLUSIONS: The results of the present study indicate that F-NaF PET-CT retains its high diagnostic accuracy in morbidly obese patients and, by inference, can be a preferred functional modality in these patients.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Usmani S, Marafi F, Ahmed N, et al. Diagnostic Challenge of Staging Metastatic Bone Disease in the Morbidly Obese Patients: A Primary Study Evaluating the Usefulness of 18F-Sodium Fluoride (NaF) PET-CT. Clin Nucl Med. 2017. PMID: 28872551. doi:10.1097/RLU.0000000000001823

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。